Westfield Capital Management Co. LP Purchases Shares of 1,294,280 Oscar Health, Inc. (NYSE:OSCR)

Westfield Capital Management Co. LP bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,294,280 shares of the company's stock, valued at approximately $27,452,000. Westfield Capital Management Co. LP owned approximately 0.54% of Oscar Health as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of OSCR. Price T Rowe Associates Inc. MD increased its holdings in Oscar Health by 153.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock worth $59,156,000 after buying an additional 2,409,160 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock worth $61,478,000 after purchasing an additional 934,600 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Oscar Health during the 2nd quarter worth approximately $14,716,000. Bank of New York Mellon Corp raised its holdings in shares of Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock worth $22,038,000 after purchasing an additional 860,226 shares during the period. Finally, Beck Bode LLC purchased a new position in Oscar Health in the first quarter valued at approximately $9,856,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of OSCR traded up $0.88 during midday trading on Monday, hitting $16.86. 4,037,425 shares of the company traded hands, compared to its average volume of 3,426,898. Oscar Health, Inc. has a one year low of $7.29 and a one year high of $23.79. The firm has a market cap of $4.17 billion, a P/E ratio of -280.95 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a 50-day moving average of $17.80 and a 200-day moving average of $18.15.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the company posted ($0.29) EPS. The business's revenue was up 68.3% on a year-over-year basis. As a group, sell-side analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares of the company's stock, valued at approximately $2,530,257.52. The trade was a 2.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mario Schlosser sold 3,198 shares of the company's stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares of the company's stock, valued at $1,384,906.18. This trade represents a 3.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 194,569 shares worth $3,433,319. 25.11% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have issued reports on OSCR shares. Piper Sandler restated an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group assumed coverage on shares of Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Finally, Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health currently has an average rating of "Moderate Buy" and a consensus price target of $22.93.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.